A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (CLL) or Small... von Parikh, Sameer A., Muchtar, Eli, Laplant, Betsy, Ding, Wei, Ailawadhi, Sikander, Koehler, Amber, Call, Timothy G., Kenderian, Saad S., Leis, Jose F., Fonder, Amie, Shi, Min, Chanan-Khan, Asher A., Pettinger, Adam, Witzig, Thomas E., Thompson, Carrie A., Villasboas, Jose C, Sholes, Jessica M, Hanson, Curtis A., Braggio, Esteban, Medina, Kay L., Slager, Susan L., Kay, Neil E.

Volltext